Pages that link to "Q44231781"

The following pages link to Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979. (Q44231781):

Displaying 39 items.

• Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation (Q26824355) (← links)
• Plasma membrane transporters in modern liver pharmacology (Q26829263) (← links)
• Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications (Q28084270) (← links)
• Olomoucine II, but not purvalanol A, is transported by breast cancer resistance protein (ABCG2) and P-glycoprotein (ABCB1) (Q28534229) (← links)
• Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography (Q28553692) (← links)
• Targeting multidrug resistance in cancer (Q29616803) (← links)
• Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer (Q30274798) (← links)
• Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML). (Q33319637) (← links)
• An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats (Q33876743) (← links)
• Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein (Q35113667) (← links)
• Reversal of MDR by verapamil analogues (Q35668684) (← links)
• Knocking down transport: applications of RNA interference in the study of drug transport proteins (Q36360814) (← links)
• Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins (Q36525551) (← links)
• Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier (Q36555565) (← links)
• Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies (Q37010772) (← links)
• Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function (Q37105870) (← links)
• Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain (Q37331814) (← links)
• Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2 (Q37409373) (← links)
• Investigational ABC transporter inhibitors (Q38001734) (← links)
• Fate of Environmental Pollutants (Q39033141) (← links)
• Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein (Q39373185) (← links)
• Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin (Q39415463) (← links)
• PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line (Q39757785) (← links)
• Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). (Q40031317) (← links)
• Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. (Q40530013) (← links)
• Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells. (Q41847288) (← links)
• Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002. (Q44619783) (← links)
• Preclinical absorption, distribution, metabolism, excretion and pharmacokinetics of a novel selective inhibitor of breast cancer resistance protein (BCRP). (Q46369173) (← links)
• Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA. (Q48213066) (← links)
• Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar (Q48230991) (← links)
• In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier. (Q48619564) (← links)
• Cell Migration Related to MDR-Another Impediment to Effective Chemotherapy? (Q50062677) (← links)
• Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs). (Q53818047) (← links)
• Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells (Q56832659) (← links)
• A Comprehensive Study Demonstrating that P-glycoprotein Function is Directly Affected by Changes in pH: Implications for Intestinal pH and Effects on Drug Absorption (Q57343266) (← links)
• Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec® ) across the mouse blood-brain barrier (Q57374265) (← links)
• Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia (Q58605916) (← links)
• MDR1 in immunity: friend or foe? (Q90326700) (← links)
• Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance (Q92542448) (← links)